Periscope Capital Inc.

SEC CIK: 0001695320
Latest filing: Aug 11, 2026

SEC filings (opens in a new tab)

SLXNW holding history

Silexion Therapeutics Corp in every 13F filed by Periscope Capital Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SLXNW overview All 13F holders of SLXNW Full Q2 2026 holdings

Shares (Q2 2025): 0; Sold out in Q2 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q3 2024

Holdings of SLXNW by Periscope Capital Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2025	0	$0	0.0%	−87,169−100.0%	Sold out	Holders
Q1 2025	87,169	$6.67K	<0.1%	00.0%	Unchanged	Holders
Q4 2024	87,169	$2.96K	<0.1%	−17,374−16.6%	Reduced	Holders
Q3 2024	104,543	$5.30K	<0.1%	+104,543	New	Holders